Quinuclidine derivatives as potential antiparasitics.

Area of Science:

• Medicinal Chemistry
• Parasitology
• Biochemistry

Background:

• Tropical parasitic diseases like Chagas' disease and leishmaniasis require novel therapeutic agents.
• Sterol biosynthesis presents a viable drug target in causative organisms.
• Squalene synthase (SQS) is a key enzyme in the sterol biosynthesis pathway.

Purpose of the Study:

• To design and synthesize novel quinuclidine derivatives.
• To evaluate these derivatives as potential inhibitors of parasite squalene synthase (SQS).
• To assess the efficacy of identified compounds against tropical parasites.

Main Methods:

• Chemical synthesis of quinuclidine derivatives.
• Enzyme inhibition assays using recombinant Leishmania major SQS.
• Selectivity testing against human SQS.
• Assessment of parasite growth inhibition and sterol biosynthesis.
• Screening against Trypanosoma brucei and Plasmodium falciparum.

Main Results:

• Discovery of several quinuclidine derivatives inhibiting Leishmania major SQS at submicromolar concentrations.
• Identification of compounds selective for parasite SQS over human SQS.
• Demonstration of inhibited growth and sterol biosynthesis in Leishmania parasites by these compounds.
• Identification of other quinuclidine derivatives inhibiting Trypanosoma brucei and Plasmodium falciparum growth via unknown mechanisms.

Conclusions:

• Quinuclidine derivatives are effective inhibitors of parasite squalene synthase (SQS).
• These compounds demonstrate potential for treating leishmaniasis and possibly other tropical parasitic diseases.
• Further investigation is warranted for compounds with unknown modes of action against Trypanosoma brucei and Plasmodium falciparum.